Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | DRD3 | P35462 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.36 |
| ▸ | HTR3B | O95264 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTR3A | P46098 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.36 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29732987 | 1.00 | GAA (0.46) | GAASMN1; SMN2L3MBTL1HPGDHTT | |
| SCHEMBL15890588 | 0.82 | TSHR (0.38) | SMN1; SMN2L3MBTL1HPGDNPSR1ALDH1A1 | |
| SCHEMBL15921413 | 0.78 | SMN1; SMN2 (0.48) | GAASMN1; SMN2L3MBTL1HPGDHTT | |
| SCHEMBL4319027 | 0.77 | DDAH1 (0.35) | SMN1; SMN2HPGDALDH1A1MAPTHTR3E | |
| SCHEMBL16449094 | 0.76 | GAA (0.55) | GAAHPGDALDH1A1DRD2DRD3 | |
| SCHEMBL16351498 | 0.76 | EPHX1 (0.33) | SMN1; SMN2L3MBTL1HPGDALDH1A1 | |
| SCHEMBL289929 | 0.75 | KDM4E (0.42) | GAASMN1; SMN2L3MBTL1HTTNPSR1 | |
| SCHEMBL27631126 | 0.75 | FGFR1 (0.40) | SMN1; SMN2HPGDALDH1A1DRD2DRD3 | |
| SCHEMBL20994196 | 0.73 | KDM4E (0.40) | GAASMN1; SMN2L3MBTL1HTTNPSR1 | |
| SCHEMBL29370031 | 0.73 | GAA (0.51) | GAASMN1; SMN2HPGDALDH1A1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2427468-B2 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PLC (GB) | 2025-06-04 | — | — | EP | claimed |
| EP-4267591-A2 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-11-01 | — | — | EP | claimed |
| CN-116802187-A | Organometallic compounds | 优米科尔股份公司及两合公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2022136049-A2 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2022-06-30 | — | — | WO | claimed |
| CN-105111132-B | One kind 2,2 ' joins the production method of carbazole | 河南省科学院化学研究所有限公司 | 2017-11-03 | — | — | CN | claimed |
| EP-2427468-B1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PLC (GB) | 2017-06-14 | — | — | EP | claimed |
| EP-2951188-B1 | PHOSPHORUS LIGANDS AND METHOD FOR THE SELECTIVE RUTHENIUM-CATALYZED HYDROAMINOMETHYLATION OF OLEFINS | EVONIK DEGUSSA GMBH (DE) | 2017-05-10 | — | — | EP | claimed |
| EP-2975019-A1 | RUTHENIUM CATALYZED HYDROAMINOMETHYLATION | Evonik Degussa GmbH (DE) | 2016-01-20 | — | — | EP | claimed |
| WO-2015063543-A1 | HYDRIDOPALLADIUM(II) HALIDES AS PREFORMED CATALYSTS FOR SUZUKI-MIYAURA CROSS-COUPLING REACTIONS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2015-05-07 | — | — | WO | claimed |
| US-8772520-B2 | Preparation of a metal complex | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2014-07-08 | — | — | US | claimed |
| US-20120116109-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-05-10 | — | — | US | claimed |
| EP-2427468-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-03-14 | — | — | EP | claimed |
| WO-2010128316-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2010-11-11 | — | — | WO | claimed |
| US-20100221647-A1 | PYRROLE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2010-09-02 | — | — | US | claimed |
| EP-2427468-B2 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PLC (GB) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025016436-A1 | PREPARATION METHOD FOR KRAS INHIBITOR, INTERMEDIATE THEREOF AND PREPARATION METHOD FOR INTERMEDIATE THEREOF | 上海济煜医药科技有限公司 | 2025-01-23 | — | — | WO | disclosed |
| US-20240317779-A1 | METAL COMPLEXES HAVING 4-H,6-H OR 8-H DIHYDROAZULENYL LIGANDS AND USE THEREOF | UMICORE AG & CO. KG (DE) | 2024-09-26 | — | — | US | disclosed |
| US-20070123707-A1 | Nitrogen-containing monodentate phosphines and their use in catalysis | DEGUSSA AG (DE) | 2007-05-31 | — | — | US | disclosed |
| EP-1625133-A2 | NITROGEN-CONTAINING MONODENTATE PHOSPHINES AND THEIR USE IN CATALYSIS | Degussa AG (DE) | 2006-02-15 | — | — | EP | disclosed |
| WO-2004101581-A2 | NITROGEN-CONTAINING MONODENTATE PHOSPHINES AND THEIR USE IN CATALYSIS | DEGUSSA AG (DE) | 2004-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123707-A1 | Nitrogen-containing monodentate phosphines and their use in catalysis | HDHD5, PNP, PHOSPHO1 | GAA 3420/4885SMN1; SMN2 4717/4885L3MBTL1 4476/4885 |
| US-20240317779-A1 | METAL COMPLEXES HAVING 4-H,6-H OR 8-H DIHYDROAZULENYL LIGANDS AND USE THEREOF | DOHH, CPNE4, MDH2 | GAA 2982/4885SMN1; SMN2 4589/4885L3MBTL1 4450/4885 |
| US-20120116109-A1 | PREPARATION OF A METAL COMPLEX | PDCD1LG2, CD274, PDCD2L | GAA 4147/4885SMN1; SMN2 2431/4885L3MBTL1 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.